Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × talazoparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Prostatic Neoplasms 9 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Endometrial Neoplasms 3 Small Cell Lung Carcinoma 2 Fallopian Tube Neoplasms 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1

Interventions

fludarabine 18 Whole-Body Irradiation 15 Cyclophosphamide 15 ruxolitinib 14 fludarabine phosphate 12 Tacrolimus 11 Specimen Handling 11 Mycophenolic Acid 11 Biopsy 10 Azacitidine 10 venetoclax 8 Peripheral Blood Stem Cell Transplantation 8 Melphalan 8 Cytarabine 8 Busulfan 7 Injections 6 Stem Cell Transplantation 5 Sirolimus 5 Daunorubicin 5 CPX-351 5 luspatercept 4 itacitinib 4 fedratinib 4 decitabine and cedazuridine drug combination 4 Liposomes 4 Granulocyte Colony-Stimulating Factor 4 ivosidenib 3 Thiotepa 3 Methotrexate 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡